Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Change in Receivables (2018 - 2019)

Historic Change in Receivables for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to $159000.0.

  • DiaMedica Therapeutics' Change in Receivables rose 16045.63% to $159000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $43000.0, marking a year-over-year decrease of 9385.71%. This contributed to the annual value of -$133000.0 for FY2024, which is 14634.15% down from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Change in Receivables of $159000.0 as of Q4 2019, which was up 16045.63% from -$448000.0 recorded in Q3 2019.
  • DiaMedica Therapeutics' Change in Receivables' 5-year high stood at $721000.0 during Q3 2018, with a 5-year trough of -$467000.0 in Q2 2018.